E Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$614K Sell
1,587
-332
-17% -$123K 0.01% 229
2026
Q1
$562K Buy
+1,919
New +$631K 0.02% 270
2025
Q2
$486K Sell
1,250
-63
-5% -$25.3K 0.02% 232
2025
Q1
$571K Sell
1,313
-112
-8% -$45K 0.03% 211
2024
Q4
$526K Buy
1,425
+760
+114% +$318K 0.03% 220
2024
Q3
$346K Sell
665
-13
-2% -$6.95K 0.02% 238
2024
Q2
$367K Sell
678
-35
-5% -$18.5K 0.02% 207
2024
Q1
$370K Buy
713
+93
+15% +$46.3K 0.02% 243
2023
Q4
$292K Buy
620
+55
+10% +$25.4K 0.02% 233
2023
Q3
$246K Sell
565
-30
-5% -$13.6K 0.02% 227
2023
Q2
$264K Sell
595
-63
-10% -$29.1K 0.02% 232
2023
Q1
$303K Sell
658
-8
-1% -$3.81K 0.02% 221
2022
Q4
$342K Sell
666
-75
-10% -$38.1K 0.03% 210
2022
Q3
$337K Buy
741
+58
+8% +$27.8K 0.03% 217
2022
Q2
$330K Sell
683
-23
-3% -$11.4K 0.03% 219
2022
Q1
$347K Sell
706
-117
-14% -$53.5K 0.01% 167
2021
Q4
$381K Sell
823
-68
-8% -$28.6K 0.01% 193
2021
Q3
$332K Buy
+891
New +$339K 0.01% 177
2021
Q1
$257K Buy
+715
New +$230K 0.02% 195

Other funds holding ELV

E Fund Management's ELV Position: Q2 2026 in Review

E Fund Management reduced its Elevance Health (ELV) stake by 17% in Q2 2026, selling an estimated $123K and leaving 1,587 shares worth $614K. The position accounts for 0.01% of the portfolio, ranked #229.

E Fund Management first reported a position in ELV in Q1 2021 and has held it in 19 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • E Fund Management held 1,587 shares of Elevance Health worth $614K as of Q2 2026.
  • E Fund Management sold 332 Elevance Health shares in Q2 2026, an estimated $123K.
  • Elevance Health made up 0.01% of E Fund Management's portfolio in Q2 2026, its #229 holding.
  • E Fund Management first reported a position in Elevance Health in Q1 2021 and has held it in 19 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.